ATE142481T1 - Dosierungsform enthaltend einen polymer mit verschiedenen molekularen gewichte - Google Patents

Dosierungsform enthaltend einen polymer mit verschiedenen molekularen gewichte

Info

Publication number
ATE142481T1
ATE142481T1 AT92911279T AT92911279T ATE142481T1 AT E142481 T1 ATE142481 T1 AT E142481T1 AT 92911279 T AT92911279 T AT 92911279T AT 92911279 T AT92911279 T AT 92911279T AT E142481 T1 ATE142481 T1 AT E142481T1
Authority
AT
Austria
Prior art keywords
dosage form
polymer
molecular weights
different molecular
form containing
Prior art date
Application number
AT92911279T
Other languages
English (en)
Inventor
Jeri D Wright
Brian L Barclay
David R Swanson
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of ATE142481T1 publication Critical patent/ATE142481T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
AT92911279T 1991-04-22 1992-04-22 Dosierungsform enthaltend einen polymer mit verschiedenen molekularen gewichte ATE142481T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/688,807 US5208037A (en) 1991-04-22 1991-04-22 Dosage forms comprising polymers comprising different molecular weights

Publications (1)

Publication Number Publication Date
ATE142481T1 true ATE142481T1 (de) 1996-09-15

Family

ID=24765867

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92911279T ATE142481T1 (de) 1991-04-22 1992-04-22 Dosierungsform enthaltend einen polymer mit verschiedenen molekularen gewichte

Country Status (17)

Country Link
US (2) US5208037A (de)
EP (1) EP0581862B1 (de)
JP (1) JP2638303B2 (de)
KR (1) KR0158466B1 (de)
AT (1) ATE142481T1 (de)
AU (1) AU655827B2 (de)
CA (1) CA2101245C (de)
DE (1) DE69213729T2 (de)
ES (1) ES2092115T3 (de)
FI (1) FI110160B (de)
IE (1) IE921269A1 (de)
MX (1) MX9201813A (de)
NO (1) NO306976B1 (de)
NZ (1) NZ242419A (de)
PT (1) PT100417B (de)
WO (1) WO1992018102A1 (de)
ZA (1) ZA922907B (de)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6764697B1 (en) * 1991-06-27 2004-07-20 Alza Corporation System for delaying drug delivery up to seven hours
HUT75616A (en) * 1992-03-17 1997-05-28 Pfizer Method for prooucing porous delivery devices
US6440457B1 (en) 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
ZA953078B (en) * 1994-04-28 1996-01-05 Alza Corp Effective therapy for epilepsies
US5914131A (en) * 1994-07-07 1999-06-22 Alza Corporation Hydromorphone therapy
US5529787A (en) * 1994-07-07 1996-06-25 Alza Corporation Hydromorphone therapy
DE69709646T2 (de) * 1996-03-12 2002-08-14 Alza Corp., Palo Alto Zusammensetzung und dosisform mit einem opioid-antagonisten
US6919373B1 (en) 1996-11-12 2005-07-19 Alza Corporation Methods and devices for providing prolonged drug therapy
EP1782798A3 (de) 1996-11-25 2008-05-21 Alza Corporation Darreichungsform mit ansteigender Dosisfreisetzung
ZA979605B (en) * 1996-11-25 1998-05-21 Alza Corp Ascending-dose dosage form.
PT946151E (pt) * 1996-11-25 2006-07-31 Alza Corp Forma de dosagem de dose crescente
US5968895A (en) 1996-12-11 1999-10-19 Praecis Pharmaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
US20070185032A1 (en) * 1996-12-11 2007-08-09 Praecis Pharmaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
US5922352A (en) * 1997-01-31 1999-07-13 Andrx Pharmaceuticals, Inc. Once daily calcium channel blocker tablet having a delayed release core
US5837379A (en) * 1997-01-31 1998-11-17 Andrx Pharmaceuticals, Inc. Once daily pharmaceutical tablet having a unitary core
GT199800127A (es) * 1997-08-29 2000-02-01 Combinaciones terapeuticas.
US6485748B1 (en) 1997-12-12 2002-11-26 Andrx Pharmaceuticals, Inc. Once daily pharmaceutical tablet having a unitary core
US6224907B1 (en) * 1998-03-06 2001-05-01 Alza Corporation Anti-asthma therapy
US6524620B2 (en) 1998-07-20 2003-02-25 Andrx Pharmaceuticals, Inc. Diltiazem controlled release formulation and method of manufacture
US7108866B1 (en) 1999-12-10 2006-09-19 Biovall Laboratories International Srl Chronotherapeutic diltiazem formulations and the administration thereof
US20060153914A1 (en) * 1999-12-10 2006-07-13 Biovail Laboratories International S.R.L. Chronotherapeutic diltiazem formulations and the administration thereof
JP2003518487A (ja) 1999-12-23 2003-06-10 ファイザー・プロダクツ・インク ヒドロゲル駆動型積層薬物製剤
DE60108222T2 (de) * 2000-02-04 2005-07-07 Alza Corp., Mountain View Abgabevorrichtung für eine Flüssigkeit sowie Beschichtungszusammensetzungen für osmotisch betriebene Abgabevorrichtungen
US8012504B2 (en) * 2000-04-28 2011-09-06 Reckitt Benckiser Inc. Sustained release of guaifenesin combination drugs
US7985420B2 (en) * 2000-04-28 2011-07-26 Reckitt Benckiser Inc. Sustained release of guaifenesin combination drugs
US7838032B2 (en) * 2000-04-28 2010-11-23 Reckitt Benckiser Inc. Sustained release of guaifenesin
US6372252B1 (en) 2000-04-28 2002-04-16 Adams Laboratories, Inc. Guaifenesin sustained release formulation and tablets
US6955821B2 (en) * 2000-04-28 2005-10-18 Adams Laboratories, Inc. Sustained release formulations of guaifenesin and additional drug ingredients
US20040001886A1 (en) * 2001-10-17 2004-01-01 Dr. Reddy's Laboratories Limited Stabilized pharmaceutical formulations containing amlodipine maleate
US8329217B2 (en) 2001-11-06 2012-12-11 Osmotica Kereskedelmi Es Szolgaltato Kft Dual controlled release dosage form
US20030185882A1 (en) * 2001-11-06 2003-10-02 Vergez Juan A. Pharmaceutical compositions containing oxybutynin
US7407778B2 (en) * 2002-02-07 2008-08-05 Pettegrew Jay W Compounds, compositions and methods for treating neuropsychiatric disorders
US8894973B2 (en) * 2002-02-07 2014-11-25 Jay W. Pettegrew Method and system for differential diagnosis of chronic schizophrenia and chronic alcoholism
JP2005523269A (ja) * 2002-02-07 2005-08-04 シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニ 老人性うつ病の治療におけるカルニチン
US20050272812A1 (en) * 2002-02-07 2005-12-08 Pettegrew Jay W Methor for use of acetyl-L-carnitine (ALCAR) for treatment of depressive disorders in humans
US20100010336A1 (en) * 2002-02-07 2010-01-14 Pettegrew Jay W Method and system for diagnosis of neuropsychiatric disorders including attention deficit hyperactivity disorder (adhd), autism, and schizophrenia
US7700074B2 (en) * 2002-02-07 2010-04-20 Pettegrew Jay W Method and system for diagnosis of neuropsychiatric disorders including chronic alcoholism
GB0203296D0 (en) * 2002-02-12 2002-03-27 Glaxo Group Ltd Novel composition
US20040005359A1 (en) * 2002-06-27 2004-01-08 Cheng Xiu Xiu Controlled release oral dosage form
US8637512B2 (en) * 2002-07-29 2014-01-28 Glaxo Group Limited Formulations and method of treatment
US20050232995A1 (en) 2002-07-29 2005-10-20 Yam Nyomi V Methods and dosage forms for controlled delivery of paliperidone and risperidone
US7815934B2 (en) 2002-09-20 2010-10-19 Alpharma Pharmaceuticals, Llc Sequestering subunit and related compositions and methods
US20060193825A1 (en) * 2003-04-29 2006-08-31 Praecis Phamaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
US20050112087A1 (en) * 2003-04-29 2005-05-26 Musso Gary F. Pharmaceutical formulations for sustained drug delivery
ES2661168T3 (es) 2003-07-12 2018-03-27 Accelerate Diagnostics, Inc. Biodetección sensible y rápida
US20120077206A1 (en) 2003-07-12 2012-03-29 Accelr8 Technology Corporation Rapid Microbial Detection and Antimicrobial Susceptibility Testing
SI2719378T1 (sl) 2006-06-19 2016-11-30 Alpharma Pharmaceuticals Llc Farmacevtski sestavki
CN100563637C (zh) * 2006-10-13 2009-12-02 北京红林制药有限公司 一种控释给药的药芯组合物和控释制剂及其制备方法
CN100563638C (zh) * 2006-10-24 2009-12-02 北京红林制药有限公司 硝苯地平控释片及其制备方法
DK2200588T3 (da) 2007-09-25 2019-07-01 Solubest Ltd Sammensætninger, som omfatter lipofile aktive forbindelser, og fremgangsmåde til fremstilling deraf
US8623418B2 (en) 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
WO2012071220A1 (en) * 2010-11-23 2012-05-31 Transcept Pharmaceuticals, Inc. Compositions and methods for once-daily administration of a trilayer osmotic tablet
US10254204B2 (en) 2011-03-07 2019-04-09 Accelerate Diagnostics, Inc. Membrane-assisted purification
US9434937B2 (en) 2011-03-07 2016-09-06 Accelerate Diagnostics, Inc. Rapid cell purification systems
US9677109B2 (en) 2013-03-15 2017-06-13 Accelerate Diagnostics, Inc. Rapid determination of microbial growth and antimicrobial susceptibility
US20160310408A1 (en) 2013-12-06 2016-10-27 Durect Corporation Compositions Comprising Antioxidant, Fluid Dispensers, and Methods Involving the Same
GB201506755D0 (en) 2015-04-21 2015-06-03 Reckitt Benckiser Llc Novel pharmaceutical formulation
US10253355B2 (en) 2015-03-30 2019-04-09 Accelerate Diagnostics, Inc. Instrument and system for rapid microorganism identification and antimicrobial agent susceptibility testing
US10023895B2 (en) 2015-03-30 2018-07-17 Accelerate Diagnostics, Inc. Instrument and system for rapid microogranism identification and antimicrobial agent susceptibility testing
US11278506B2 (en) 2015-10-09 2022-03-22 Rb Health (Us) Llc Pharmaceutical formulation

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4765989A (en) * 1983-05-11 1988-08-23 Alza Corporation Osmotic device for administering certain drugs
NZ206600A (en) * 1983-05-11 1987-01-23 Alza Corp Osmotic drug delivery device
US4783337A (en) * 1983-05-11 1988-11-08 Alza Corporation Osmotic system comprising plurality of members for dispensing drug
GB2140487B (en) * 1983-05-25 1987-03-11 Baker Ham & Co Ltd Improvements relating to penstocks
US4717566A (en) * 1984-03-19 1988-01-05 Alza Corporation Dosage system and method of using same
US4863456A (en) * 1986-04-30 1989-09-05 Alza Corporation Dosage form with improved delivery capability
US4743248A (en) * 1986-08-11 1988-05-10 Alza Corporation Dosage form for delivering acid sensitive beneficial agent
US4946687A (en) * 1987-10-02 1990-08-07 Alza Corporation Dosage form for treating cardiovascular diseases
US4816263A (en) * 1987-10-02 1989-03-28 Alza Corporation Dosage form for treating cardiovascular diseases comprising isradipine
US4950486A (en) * 1987-10-02 1990-08-21 Alza Corporation Dosage form for treating cardiovascular diseases
US4904474A (en) * 1988-01-25 1990-02-27 Alza Corporation Delivery of drug to colon by oral disage form
US4837111A (en) * 1988-03-21 1989-06-06 Alza Corporation Dosage form for dispensing drug for human therapy
US4859470A (en) * 1988-06-02 1989-08-22 Alza Corporation Dosage form for delivering diltiazem
US4966769A (en) * 1988-06-02 1990-10-30 Alza Corporation Method for delivering dosage form for diltiazem
US4902514A (en) * 1988-07-21 1990-02-20 Alza Corporation Dosage form for administering nilvadipine for treating cardiovascular symptoms
US4948593A (en) * 1989-05-15 1990-08-14 Alza Corporation Osmotic dosage form comprising an estrogen and a progestogen
US5024843A (en) * 1989-09-05 1991-06-18 Alza Corporation Oral hypoglycemic glipizide granulation

Also Published As

Publication number Publication date
NO306976B1 (no) 2000-01-24
JPH06506952A (ja) 1994-08-04
FI110160B (fi) 2002-12-13
FI934653L (fi) 1993-10-21
CA2101245C (en) 2002-06-25
EP0581862A1 (de) 1994-02-09
ZA922907B (en) 1993-02-24
PT100417A (pt) 1993-08-31
WO1992018102A1 (en) 1992-10-29
PT100417B (pt) 1999-06-30
ES2092115T3 (es) 1996-11-16
AU1917392A (en) 1992-11-17
EP0581862B1 (de) 1996-09-11
FI934653A0 (fi) 1993-10-21
US5326571A (en) 1994-07-05
KR0158466B1 (ko) 1998-12-01
NZ242419A (en) 1994-07-26
JP2638303B2 (ja) 1997-08-06
US5208037A (en) 1993-05-04
DE69213729T2 (de) 1997-01-30
NO933728L (no) 1993-10-18
IE921269A1 (en) 1992-11-04
AU655827B2 (en) 1995-01-12
CA2101245A1 (en) 1992-10-23
DE69213729D1 (de) 1996-10-17
MX9201813A (es) 1992-10-01

Similar Documents

Publication Publication Date Title
ATE142481T1 (de) Dosierungsform enthaltend einen polymer mit verschiedenen molekularen gewichte
FI913248A0 (fi) Kontrollerat frigoerande fast farmaceutisk doseringsform.
IL103981A (en) CDw52-SPECIFIC ANTIBODY FOR TREATMENT OF MULTIPLE SCLEROSIS
DE69632046D1 (de) Automatisches infusionssystem mit dosierspender
DK0584001T3 (da) Anvendelse af taxol til fremstilling af et medikament til behandling af cancer
FI930862A0 (fi) En doseringsform foer tidsvarierande moenster av laekemedeloeverlaotelse
EP0665729A4 (de) Diagnostische und therapeutische Einheiten enthaltend biokompatibele Polymere.
DE59608732D1 (de) Lagerstabile arzneiformen
FR2680760B1 (fr) Cartouche pour la distribution integrale de masses pateuses.
KR880011197A (ko) 위장장해를 치료하기 위한 조성물 및 방법
DE69112735D1 (de) Stabilisierte Monomerenzusammensetzungen.
ZA93821B (en) New derivatives of baccatin III and of 10-deacetyibaccatin III, their preparation and the pharmaceutical compositions which contain them.
FR2703995B1 (fr) 5-acylamino 1,2,4-thiadiazoles, leur preparation et compositions pharmaceutiques en contenant.
AU668767B2 (en) Oral medicament form
NO179504C (no) Legemiddel i form av en tablett inneholdende diritromycin
EP1782798A3 (de) Darreichungsform mit ansteigender Dosisfreisetzung
BR9201398A (pt) Emprego de oligouretanas com pesos moleculares de 5.000 ate 50.000
IT1248073B (it) Composti polimerici, contenenti gruppi amminici ingombrati stericamente, adatti come stabilizzanti e composizioni polimeriche comprendenti gli stessi.
FR2672806B1 (fr) Dispositif d'arret pour dispositif de dosage d'un evaporateur d'anesthesique.
FR2692798B1 (fr) Plaquette d'assurage pour paroi d'escalade, naturelle ou artificielle.
FR2729575B1 (fr) Dispositif d'ionophorese pour l'administration transcutanee d'un principe actif de type glycosaminoglycane anionique de basse masse moleculaire
ZA926829B (en) Novel substituted taxanes and pharmaceutical compositions containing them.
JPS5223144A (en) Polymer composition stabilised against ultraviolet rays
CO4600721A1 (es) Nueva formulacion agroquimica
ZA921003B (en) Dose by weight medicine dropper.